
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target
Hantao Lou, Guang Sheng Ling, Xuetao Cao
Journal of Autoimmunity (2022) Vol. 132, pp. 102861-102861
Closed Access | Times Cited: 80
Hantao Lou, Guang Sheng Ling, Xuetao Cao
Journal of Autoimmunity (2022) Vol. 132, pp. 102861-102861
Closed Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity
Chang H. Kim
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 4, pp. 341-350
Closed Access | Times Cited: 124
Chang H. Kim
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 4, pp. 341-350
Closed Access | Times Cited: 124
The role of inflammation in autoimmune disease: a therapeutic target
Yu Xiang, Mingxue Zhang, D.Y. Jiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 51
Yu Xiang, Mingxue Zhang, D.Y. Jiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 51
Unveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR-T therapies in autoimmunity
Aaron Bodansky, David Yu, Alysa Rallistan, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 13
Open Access | Times Cited: 16
Aaron Bodansky, David Yu, Alysa Rallistan, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 13
Open Access | Times Cited: 16
Potential clinical implications of molecular mimicry‐induced autoimmunity
Bandar A. Suliman
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 15
Bandar A. Suliman
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 15
T follicular helper cells in autoimmune diseases
Xindi Wei, Xiaoyin Niu
Journal of Autoimmunity (2022) Vol. 134, pp. 102976-102976
Closed Access | Times Cited: 57
Xindi Wei, Xiaoyin Niu
Journal of Autoimmunity (2022) Vol. 134, pp. 102976-102976
Closed Access | Times Cited: 57
Endocrine-disrupting chemicals and autoimmune diseases
Ronggui Huang, Xian‐Bao Li, Yiyu Wang, et al.
Environmental Research (2023) Vol. 231, pp. 116222-116222
Closed Access | Times Cited: 28
Ronggui Huang, Xian‐Bao Li, Yiyu Wang, et al.
Environmental Research (2023) Vol. 231, pp. 116222-116222
Closed Access | Times Cited: 28
Metabolic dysregulation of lymphocytes in autoimmune diseases
Shuyi Wang, Niansheng Yang, Hui Zhang
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 7, pp. 624-637
Closed Access | Times Cited: 12
Shuyi Wang, Niansheng Yang, Hui Zhang
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 7, pp. 624-637
Closed Access | Times Cited: 12
Inflammasome Molecular Insights in Autoimmune Diseases
Monica Neamţu, Veronica Bild, Alexandru Vasincu, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3502-3532
Open Access | Times Cited: 9
Monica Neamţu, Veronica Bild, Alexandru Vasincu, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3502-3532
Open Access | Times Cited: 9
Immune‐related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity
Namrata Singh, Anne M. Hocking, Jane H. Buckner
Immunological Reviews (2023) Vol. 318, Iss. 1, pp. 81-88
Closed Access | Times Cited: 20
Namrata Singh, Anne M. Hocking, Jane H. Buckner
Immunological Reviews (2023) Vol. 318, Iss. 1, pp. 81-88
Closed Access | Times Cited: 20
B cell metabolism in autoimmune diseases: signaling pathways and interventions
Jingyue Li, Mingjiu Zhao, Wenjun Luo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Jingyue Li, Mingjiu Zhao, Wenjun Luo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Peripheral helper T cells in human diseases
Xueyang Zou, Feifei Huo, Lulu Sun, et al.
Journal of Autoimmunity (2024) Vol. 145, pp. 103218-103218
Open Access | Times Cited: 6
Xueyang Zou, Feifei Huo, Lulu Sun, et al.
Journal of Autoimmunity (2024) Vol. 145, pp. 103218-103218
Open Access | Times Cited: 6
Serum lipid profile in systemic lupus erythematosus
Jingxiu Xuan, Chaoqiong Deng, Huiqin Lu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Jingxiu Xuan, Chaoqiong Deng, Huiqin Lu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Enhancement of CD8+T Cell Cytotoxicity Activity by IFN-α Implies Alternative Pathologic Role in Systemic Lupus Erythematosus
Chenxing Zhang, You-ying Mao, Yehui Tan, et al.
Journal of Translational Autoimmunity (2025) Vol. 10, pp. 100276-100276
Open Access
Chenxing Zhang, You-ying Mao, Yehui Tan, et al.
Journal of Translational Autoimmunity (2025) Vol. 10, pp. 100276-100276
Open Access
Dysregulated Intestinal Host–Microbe Interactions in Systemic Lupus Erythematosus: Insights from Patients and Mouse Models
Miki Kume, Jehangir Din, Daniel F. Zegarra-Ruiz
Microorganisms (2025) Vol. 13, Iss. 3, pp. 556-556
Open Access
Miki Kume, Jehangir Din, Daniel F. Zegarra-Ruiz
Microorganisms (2025) Vol. 13, Iss. 3, pp. 556-556
Open Access
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
Xiaofeng Dai, Yuting Fan, Xiaofeng Zhao
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Xiaofeng Dai, Yuting Fan, Xiaofeng Zhao
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
High disease activity correlate with decreased serum calcium in systemic lupus erythematosus
Xinglin Du, Yuanyuan Che, Yi Yuan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Xinglin Du, Yuanyuan Che, Yi Yuan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
An increase in IL-10-producing DNT cells is associated with the pathogenesis of pediatric SLE
Qixin Wang, Shipeng Li, Yi Wei, et al.
Clinical Immunology (2025), pp. 110490-110490
Closed Access
Qixin Wang, Shipeng Li, Yi Wei, et al.
Clinical Immunology (2025), pp. 110490-110490
Closed Access
Systemic Lupus Erythematosus Exacerbates Hip Arthritis by Promoting Chondrocyte Pyroptosis in the Femoral Head via Activating the NF‐κB Pathway
X. Fang, Helou Zhang, Huiqing Zhou, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 7
Open Access
X. Fang, Helou Zhang, Huiqing Zhou, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 7
Open Access
Construction and evaluation of glucocorticoid dose prediction model based on genetic and clinical characteristics of patients with systemic lupus erythematosus
Xin Luo, Jinjun Zhao, Danfeng Zou, et al.
International Journal of Immunopathology and Pharmacology (2025) Vol. 39
Open Access
Xin Luo, Jinjun Zhao, Danfeng Zou, et al.
International Journal of Immunopathology and Pharmacology (2025) Vol. 39
Open Access
Jieduquyuziyin prescription alleviates lupus development via inhibiting neddylation pathway to promote Bim-induced apoptosis of double negative T cells
Yiping Li, Qingchi Duan, Chenxi Wang, et al.
Journal of Ethnopharmacology (2024), pp. 118884-118884
Closed Access | Times Cited: 4
Yiping Li, Qingchi Duan, Chenxi Wang, et al.
Journal of Ethnopharmacology (2024), pp. 118884-118884
Closed Access | Times Cited: 4
Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome
Fernanda-Isadora Corona-Meraz, Mónica Vázquez-Del Mercado, Flavio Sandoval-García, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1988-1988
Open Access | Times Cited: 3
Fernanda-Isadora Corona-Meraz, Mónica Vázquez-Del Mercado, Flavio Sandoval-García, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1988-1988
Open Access | Times Cited: 3
Inhibition of GRK2 ameliorates the pristane-induced mouse SLE model by suppressing plasma cells differentiation
Dafei Han, Chunru Jiang, Huihui Xu, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112557-112557
Closed Access | Times Cited: 3
Dafei Han, Chunru Jiang, Huihui Xu, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112557-112557
Closed Access | Times Cited: 3
Lymphocytes Change Their Phenotype and Function in Systemic Lupus Erythematosus and Lupus Nephritis
Eleni Moysidou, Michalis Christodoulou, Γεώργιος Λιούλιος, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10905-10905
Open Access | Times Cited: 3
Eleni Moysidou, Michalis Christodoulou, Γεώργιος Λιούλιος, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10905-10905
Open Access | Times Cited: 3
Immunosensors for Autoimmune-Disease-Related Biomarkers: A Literature Review
Chrysoula‐Evangelia Karachaliou, Evangelia Livaniou
Sensors (2023) Vol. 23, Iss. 15, pp. 6770-6770
Open Access | Times Cited: 7
Chrysoula‐Evangelia Karachaliou, Evangelia Livaniou
Sensors (2023) Vol. 23, Iss. 15, pp. 6770-6770
Open Access | Times Cited: 7
Anti-Toxoplasma gondii antibodies as a risk factor for the prevalence and severity of systemic lupus erythematosus
Zhongzhen Li, Zhiwei Lei, Wanying Yang, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Zhongzhen Li, Zhiwei Lei, Wanying Yang, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2